A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)

Overview of attention for article published in Orphanet Journal of Rare Diseases, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 39 X posts from 21 X users, with an upper bound of 73,041 followers.

RT @bvsspa: 📗 A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study) de @EASPsalud @…

RT @bvsspa: 📗 A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study) de @EASPsalud @…

RT @bvsspa: 📗 A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study) de @EASPsalud @…

📗 A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study) de @EASPsalud @HUVMacarena @ibsGRANADA depositado en ⬇️ ⬇️⬇️ https://t.co/d3AUlimA7f #repositoriosalud #OA #ProduccionCientificaSSPA

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 35 additional X posts.